Ambler, PA, United States of America

Craig A McKelvey

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Craig A McKelvey: Innovator in CETP Inhibitor Formulations

Introduction

Craig A McKelvey is a notable inventor based in Ambler, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of CETP inhibitors. With a total of 3 patents to his name, McKelvey's work focuses on enhancing the bioavailability and effectiveness of these compounds.

Latest Patents

One of McKelvey's latest patents is for self-emulsifying formulations of CETP inhibitors. This innovative liquid formulation for oral administration improves bioavailability compared to conventional solid formulations. The formulation includes the CETP inhibitor, or a pharmaceutically acceptable salt thereof, an oil, and one or more nonionic surfactants with a hydrophilic lipophilic balance (HLB) greater than 10. Another significant patent involves polymer formulations of CETP inhibitors. This pharmaceutical composition comprises a CETP inhibiting compound, a concentration-enhancing polymer, and optionally one or more surfactants. The composition is designed to raise HDL-cholesterol and lower LDL-cholesterol, showcasing its potential therapeutic benefits.

Career Highlights

Craig A McKelvey is currently employed at Merck Sharp & Dohme Corporation, where he continues to advance his research in pharmaceutical formulations. His work has been instrumental in developing innovative solutions that address critical health issues related to cholesterol management.

Collaborations

Some of McKelvey's coworkers include Sarah Geers and Dina Zhang, who contribute to the collaborative environment at Merck Sharp & Dohme Corporation. Their combined expertise fosters innovation and drives the development of new pharmaceutical products.

Conclusion

Craig A McKelvey's contributions to the field of CETP inhibitors highlight his role as a leading inventor in pharmaceutical formulations. His innovative patents and ongoing work at Merck Sharp & Dohme Corporation continue to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…